NCT04649502View on ClinicalTrials.gov

Metformin for the Treatment of Hidradenitis Suppurativa (HS)

PHASE3CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

January 25, 2021

Primary Completion Date

January 29, 2023

Study Completion Date

August 23, 2023

Conditions
Hidradenitis Suppurativa
Interventions
COMBINATION_PRODUCT

Metformin

Metformin in combination with doxycycline

Trial Locations (1)

Unknown

Erasmus MC, Rotterdam

All Listed Sponsors
lead

K.R. van Straalen

OTHER

NCT04649502 - Metformin for the Treatment of Hidradenitis Suppurativa (HS) | Biotech Hunter | Biotech Hunter